209 related articles for article (PubMed ID: 23722320)
1. Plasma levels of phospholipase A2-IIA in patients with different types of malignancies: prognosis and association with inflammatory and coagulation biomarkers.
Menschikowski M; Hagelgans A; Schuler U; Froeschke S; Rosner A; Siegert G
Pathol Oncol Res; 2013 Oct; 19(4):839-46. PubMed ID: 23722320
[TBL] [Abstract][Full Text] [Related]
2. Plasma secretory phospholipase A2-IIa as a potential biomarker for lung cancer in patients with solitary pulmonary nodules.
Kupert E; Anderson M; Liu Y; Succop P; Levin L; Wang J; Wikenheiser-brokamp K; Chen P; Pinney SM; Macdonald T; Dong Z; Starnes S; Lu S
BMC Cancer; 2011 Dec; 11():513. PubMed ID: 22151235
[TBL] [Abstract][Full Text] [Related]
3. Secretory phospholipase A2-IIa is a target gene of the HER/HER2-elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer.
Oleksowicz L; Liu Y; Bracken RB; Gaitonde K; Burke B; Succop P; Levin L; Dong Z; Lu S
Prostate; 2012 Jul; 72(10):1140-9. PubMed ID: 22127954
[TBL] [Abstract][Full Text] [Related]
4. Serum secretory phospholipase A2-IIa (sPLA2-IIA) levels in patients surviving acute myocardial infarction.
Xin H; Chen ZY; Lv XB; Liu S; Lian ZX; Cai SL
Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):999-1004. PubMed ID: 23661511
[TBL] [Abstract][Full Text] [Related]
5. Group IIA Secretory Phospholipase A
Akinkuolie AO; Lawler PR; Chu AY; Caulfield M; Mu J; Ding B; Nyberg F; Glynn RJ; Ridker PM; Hurt-Camejo E; Chasman DI; Mora S
Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):1182-1190. PubMed ID: 31070471
[TBL] [Abstract][Full Text] [Related]
6. Group IIA secreted phospholipase A2 is associated with the pathobiology leading to COVID-19 mortality.
Snider JM; You JK; Wang X; Snider AJ; Hallmark B; Zec MM; Seeds MC; Sergeant S; Johnstone L; Wang Q; Sprissler R; Carr TF; Lutrick K; Parthasarathy S; Bime C; Zhang HH; Luberto C; Kew RR; Hannun YA; Guerra S; McCall CE; Yao G; Del Poeta M; Chilton FH
J Clin Invest; 2021 Oct; 131(19):. PubMed ID: 34428181
[TBL] [Abstract][Full Text] [Related]
7. Serum amyloid A, phospholipase A₂-IIA and C-reactive protein as inflammatory biomarkers for prostate diseases.
Menschikowski M; Hagelgans A; Fuessel S; Mareninova OA; Asatryan L; Wirth MP; Siegert G
Inflamm Res; 2013 Dec; 62(12):1063-72. PubMed ID: 24061501
[TBL] [Abstract][Full Text] [Related]
8. Secretory phospholipase A2-IIa upregulates HER/HER2-elicited signaling in lung cancer cells.
Dong Z; Meller J; Succop P; Wang J; Wikenheiser-Brokamp K; Starnes S; Lu S
Int J Oncol; 2014 Sep; 45(3):978-84. PubMed ID: 24913497
[TBL] [Abstract][Full Text] [Related]
9. Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer.
Dong Z; Liu Y; Scott KF; Levin L; Gaitonde K; Bracken RB; Burke B; Zhai QJ; Wang J; Oleksowicz L; Lu S
Carcinogenesis; 2010 Nov; 31(11):1948-55. PubMed ID: 20837598
[TBL] [Abstract][Full Text] [Related]
10. Elevated Type II Secretory Phospholipase A2 Increases the Risk of Early Atherosclerosis in Patients with Newly Diagnosed Metabolic Syndrome.
Sun CQ; Zhong CY; Sun WW; Xiao H; Zhu P; Lin YZ; Zhang CL; Gao H; Song ZY
Sci Rep; 2016 Dec; 6():34929. PubMed ID: 27941821
[TBL] [Abstract][Full Text] [Related]
11. CD64 and Group II Secretory Phospholipase A2 (sPLA2-IIA) as Biomarkers for Distinguishing Adult Sepsis and Bacterial Infections in the Emergency Department.
Tan TL; Ahmad NS; Nasuruddin DN; Ithnin A; Tajul Arifin K; Zaini IZ; Wan Ngah WZ
PLoS One; 2016; 11(3):e0152065. PubMed ID: 27003588
[TBL] [Abstract][Full Text] [Related]
12. Expression of Secretory Phospholipase A2 Group IIa in Breast Cancer and Correlation to Prognosis in a Cohort of Advanced Breast Cancer Patients.
Jespersen SS; Stovgaard ES; Nielsen D; Christensen TD; Buhl ASK; Christensen IJ; Balslev E
Appl Immunohistochem Mol Morphol; 2021 Jan; 29(1):e5-e9. PubMed ID: 32217848
[TBL] [Abstract][Full Text] [Related]
13. Increased expression and activity of group IIA and X secretory phospholipase A2 in peritumoral versus central colon carcinoma tissue.
Tribler L; Jensen LT; Jørgensen K; Brünner N; Gelb MH; Nielsen HJ; Jensen SS
Anticancer Res; 2007; 27(5A):3179-85. PubMed ID: 17970059
[TBL] [Abstract][Full Text] [Related]
14. Circulating secretory phospholipase A2 activity and risk of incident coronary events in healthy men and women: the EPIC-Norfolk study.
Mallat Z; Benessiano J; Simon T; Ederhy S; Sebella-Arguelles C; Cohen A; Huart V; Wareham NJ; Luben R; Khaw KT; Tedgui A; Boekholdt SM
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1177-83. PubMed ID: 17303774
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of plasma levels of secretory type II phospholipase A2 in patients with unstable angina pectoris.
Kugiyama K; Ota Y; Sugiyama S; Kawano H; Doi H; Soejima H; Miyamoto S; Ogawa H; Takazoe K; Yasue H
Am J Cardiol; 2000 Oct; 86(7):718-22. PubMed ID: 11018189
[TBL] [Abstract][Full Text] [Related]
16. Group IIa secretory phospholipase A2 (sPLA2IIa) and progression in patients with lung cancer.
Wang M; Hao FY; Wang JG; Xiao W
Eur Rev Med Pharmacol Sci; 2014; 18(18):2648-54. PubMed ID: 25317799
[TBL] [Abstract][Full Text] [Related]
17. Point of care testing of phospholipase A2 group IIA for serological diagnosis of rheumatoid arthritis.
Liu NJ; Chapman R; Lin Y; Mmesi J; Bentham A; Tyreman M; Abraham S; Stevens MM
Nanoscale; 2016 Feb; 8(8):4482-5. PubMed ID: 26854217
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II type 1-receptor antagonism prevents type IIA secretory phospholipase A2-dependent lipid peroxidation.
Luchtefeld M; Bandlow N; Tietge UJ; Grote K; Pfeilschifter J; Kaszkin M; Beck S; Drexler H; Schieffer B
Atherosclerosis; 2007 Sep; 194(1):62-70. PubMed ID: 17069818
[TBL] [Abstract][Full Text] [Related]
19. Halogenated phospholipids regulate secretory phospholipase A2 group IIA activity.
Korotaeva A; Samoilova E; Pavlunina T; Panasenko OM
Chem Phys Lipids; 2013; 167-168():51-6. PubMed ID: 23438648
[TBL] [Abstract][Full Text] [Related]
20. The association of PLA2G2A single nucleotide polymorphisms with type IIa secretory phospholipase A2 level but not its activity in patients with stable coronary heart disease.
Shuvalova YA; Khasanova ZB; Kaminnaya VI; Samoilova EV; Korotaeva AA; Rubanovich AV; Kaminnyi AI
Gene; 2015 Jun; 564(1):29-34. PubMed ID: 25794429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
